Pinned Tweet
Fantastic work by @TheLancet team. It was wonderful chatting with you. Check out our episode about #AI in #Pathology 🔬🤖🧬 and the other cool topics as well 🚀 #Podcast #Clinical #Research #TheLancet #Pulse
Launching The Lancet Pulse 🚀
From xenotransplantation to psychedelic drug research, The Lancet Pulse translates science into practical insights about new clinical research—and why it matters.
Listen today: spkl.io/6015AQjHW
Sebastian retweeted
We will soon be hiring postdocs, engineers and researchers (on site in Heidelberg, DE) in:
- Biomedical AI (multimodal foundation models, biomarkers, agents)
- Robotics (lab automation, physical action surfaces for agents)
- AI social sciences (multi-agent systems, agent "civilizations")
- Deploying AI in a large hospital system
More info at imai-heidelberg.de and kather.ai
If you are interested in learning more, reach out to [email protected]
Sebastian retweeted
📝 The EU does not have one framework for early-stage #medicaldevice clinical trials, it has 27. In our recent paper in @natBME, we critically review EU regulations and call for harmonization: rdcu.be/fw2pk
#MDR #digitalhealth #medicalAI
Sebastian retweeted
Where are we headed with thinking machines?
Our new perspective on large medical reasoning models
nature.com/articles/s41551-0…
@natBME @HongYuZhou14 @AdamRodmanMD @pranavrajpurkar
Sebastian retweeted
We stress tested many frontier AI models for multimodal medical reasoning (including GPT-5, Claude 3.5, Gemini 2.5 Pro). They’re not ready. Faulty reasoning, use of inappropriate shortcuts, hallucinations. Published today @NatureMedicine nature.com/articles/s41591-0…
Sebastian retweeted
AI in medicine is moving rapidly to take on much broader tasks than ever, some not fully envisioned. It's not proven in real medicine yet, but the results of the 2 new @Nature papers this week foreshadow where we may be headed.
erictopol.substack.com/p/age…
Sebastian retweeted
Today @Nature published 2 new AI medical agentic models that take capabilities to a new level, from end-to-end care after presentation to the emergency department and longitudinally through 3 out-patient visits. There's a lot to unpack.
Summarized in a new Ground Truths post.
erictopol.substack.com/p/age…
Sebastian retweeted
very happy to share our lab's latest work, published today in @Cancer_Cell : sciencedirect.com/science/ar…. We show that we can decompose pathology images of cancer tissue into their constituent parts, measure tissue patterns with AI, and that these tissue patterns (1/n)
Sebastian retweeted
We are hiring postdocs and research software engineers to work on agentic AI in healthcare, doing both research and real implementation inside a hospital, starting October this year.
If you would like to be part of a top team in Europe working on this, please reach out.
Sebastian retweeted
You can’t overstate the importance of this @NEJM manuscript:
Daraxonrasib in RAS-mutated #PancreaticCancer.
The notion that mutant RAS is now a valuable therapeutic target will change the treatment landscape of numerous #cancers.
#pancsm @OncoAlert
nejm.org/doi/full/10.1056/NE…
Jakob Nikolas Kather chaired today's #AACR26 Plenary Session on "The AI Revolution in Cancer Research," featuring Jure Leskovec, Bo Wang, Suchi Saria, and Faisal Mahmood. @jnkath @jure @BoWang87 @suchisaria @AI4Pathology
Sebastian retweeted
After years of work, our paper is now out in @npjDigitalMed We developed an AI for polyp detection and tested it in a randomized clinical trial in GI practices. The software is freely available via our lab website. nature.com/articles/s41746-0… #AI #Gastroenterology #DigitalHealth
Sebastian retweeted
We’ve trained a multimodal AI model to turn routine pathology slides into spatial proteomics, with the potential to reduce time and cost while expanding access to cancer care.
Sebastian retweeted
Everyone’s hyped about “AI for Science.” in 2025! At the end of the year, please allow me to share my unease and optimism, specifically about AI & biology.
After spending another year deep in biological foundation models, healthcare AI, and drug discovery, here are 3 lessons I learned in 2025.
1. Biology is not “just another modality.”
The biggest misconception I still see:
“Biology is text + images + graphs. Just scale transformers.”
No. Biology is causal, hierarchical, stochastic, and incomplete in ways that language and vision are not.
Tokens don’t correspond cleanly to reality.
Labels are sparse, biased, and often wrong.
Ground truth is conditional, context-dependent, and sometimes unknowable.
We’ve made real progress—single-cell, imaging, genomics, EHRs are finally being modeled jointly—but the hard truth is this:
Most biological signals are not supervised problems waiting for better loss functions.
They are intervention-driven problems. They demand perturbations, counterfactuals, and mechanisms, beyond just prediction.
Scaling obviously helps. But without causal structure, scaling mostly gives you sharper correlations.
2025 reinforced my belief that biological foundation models must be built around perturbation, uncertainty, and actionability, not just representation learning.
2. Benchmarks are holding biology back more than compute is.
Let’s be honest: Benchmarking in AI & biology is still broken.
Everyone reports SOTA. Everyone picks a different dataset slice.
Everyone tunes for a different metric. Everyone avoids prospective validation.
We’ve imported the worst habits of ML benchmarking into a domain where stakes are much higher. In biology and healthcare, a 1% gain that doesn’t transfer is worse than useless—it’s misleading.
What’s missing isn’t more benchmarks. It’s hard benchmarks:
•Prospective, not retrospective
•Perturbation-based, not static
•Multi-site, not single-lab
•Failure-aware, not leaderboard-optimized
If your model only works on the dataset that created it, it’s not a foundation model—it’s a dataset artifact.
In 2026, we need fewer flashy plots and more humility, rigor, and negative results.
3. “Reasoning” in biology is not chain-of-thought.
There’s a growing tendency to directly apply the word reasoning onto biological LLMs.
Let’s be careful.
Biological reasoning isn’t verbal fluency, longer context windows, or prettier explanations. Those are surface-level improvements. Real reasoning in biology shows up elsewhere: in forming hypotheses, deciding which experiments to run, updating beliefs when perturbations fail, and constantly trading off cost, risk, and uncertainty.
A model that explains a pathway beautifully but can’t decide which experiment to run next is not reasoning, it’s narrating.
2025 convinced me that the future lies in agentic biological AI:
systems that couple foundation models with experimentation, simulation, and decision-making loops.
Closing thought:
AI & biology is not lagging behind AI for code or language. It’s just playing a harder game.
The constraints are real. The data is messy. The feedback loops are slow. The consequences matter.
If 2025 clarified anything for me, it’s this:
We won’t make progress by treating biology like text. We’ll make progress by building AI that behaves more like a scientist : skeptical, iterative, and willing to be wrong.
Onward to 2026.
Sebastian retweeted
Developing guidance in #AI is challenging as technology evolves rapidly. ESMO task forces have developed long-lasting recommendations to support the responsible use of AI in #oncology. Read more in the #ESMODailyReporter 📌 ow.ly/yh0750XLkKA
#HealthAI #DigitalOncology
Sebastian retweeted
One year after its launch, ESAC announces its 1st Annual Meeting.
📅 May 7–8, 2026
📍 Politecnico di Milano (Via Bonardi 9, 20133 Milan)
📢 Call for abstracts open until Feb 3, 2026
For details, visit the conference's website aiforoncology.it/
Registrations opening soon
Sebastian retweeted
My lab (kather.ai) will soon be looking for multiple postdocs / research software engineers in the field of agentic AI in cancer research.
Our team recently published the first tumor board agent and we are planning to scale this up nature.com/articles/s43018-0… Other interests of our lab include multimodal medical AI applied to large clinical datasets.
Previous graduates from the lab went on to have independent research careers at academic institutions across the world, or founded their own successful startup companies.
Please get in touch if you are interested to learn more, official job advert will follow.
Sebastian retweeted
🚀 Another important piece of AI research from @fau together with Andreas Kist and Toni Gostian. Three years of hard work led to an open #multimodal dataset for #PrecisionOncology in #HeadAndNeckCancer (#HNSCC): HANCOCK (n=763) spans histology images, immune cell data, clinical follow up data, lab data, pathology & surgery reports. We integrated all these data with ML + foundation-models and reached superior outcome prediction than regular clinical or pathological classifications do. ‼️huge advance for HNSCC patients. Paper: nature.com/articles/s41467-0…
@NatureComms @UniFAU @Hornegger @niklas_kluemper #AI #DigitalPathology #OpenData #OpenScience
➡️whole data set can be downloaded here: hancock.research.uni-erlange…
Key take aways 👇
Sebastian retweeted
This study developed and evaluated an autonomous clinical artificial intelligence agent leveraging GPT-4 and multimodal precision oncology tools to support personalized cancer decision-making
nature.com/articles/s43018-0…



























